Inappropriate behavior and various adverse behavioral outcomes have already been described when utilizing benzodiazepines.Impact of coadministration of a twin CYP3A4 and CYP2C19 inhibitor with fedratinib hasn't been studied.enzalutamide will reduce the extent or effect of diazepam by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warn